c56699_8k.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Send us Feedback

Enzon Pharmaceuticals (ENZN)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

Annual Reports

Quarterly Reports

8-K

8-K (Feb 12, 2013)8-K (Dec 20, 2012)8-K (Nov 30, 2012)8-K (Oct 31, 2012)8-K (Aug 1, 2012)8-K (Jun 26, 2012)8-K (May 22, 2012)8-K (May 7, 2012)8-K (May 2, 2012)8-K (Mar 12, 2012)8-K (Feb 13, 2012)8-K (Dec 9, 2011)8-K (Nov 30, 2011)8-K (Nov 23, 2011)8-K (Nov 3, 2011)8-K (Oct 17, 2011)8-K (Sep 22, 2011)8-K (Sep 20, 2011)8-K (Aug 17, 2011)8-K (Aug 8, 2011)8-K (Aug 4, 2011)8-K (Jun 20, 2011)8-K (May 31, 2011)8-K (May 19, 2011)8-K (May 16, 2011)8-K (May 6, 2011)8-K (Mar 24, 2011)8-K (Mar 17, 2011)8-K (Feb 17, 2011)8-K (Jan 25, 2011)8-K (Dec 21, 2010)8-K (Dec 7, 2010)8-K (Nov 12, 2010)8-K (Nov 2, 2010)8-K (Aug 3, 2010)8-K (Jul 15, 2010)8-K (Jul 8, 2010)8-K (Jun 18, 2010)8-K (May 10, 2010)8-K (May 7, 2010)8-K (Apr 22, 2010)8-K (Mar 8, 2010)8-K (Feb 23, 2010)8-K (Feb 17, 2010)8-K (Feb 5, 2010)8-K (Jan 29, 2010)8-K (Jan 21, 2010)8-K (Nov 12, 2009)8-K (Nov 9, 2009)8-K (Nov 3, 2009)8-K (Aug 4, 2009)8-K (Jul 24, 2009)8-K (May 7, 2009)8-K (Feb 19, 2009)8-K (Jan 21, 2009)8-K (Dec 4, 2008)8-K (Nov 5, 2008)8-K (Aug 25, 2008)8-K (Aug 18, 2008)8-K (Aug 13, 2008)8-K (Aug 6, 2008)8-K (Jun 20, 2008)8-K (May 28, 2008)8-K (May 7, 2008)8-K (Feb 14, 2008)8-K (Feb 12, 2008)8-K (Jan 8, 2008)8-K (Nov 26, 2007)8-K (Nov 13, 2007)8-K (Oct 30, 2007)8-K (Aug 20, 2007)8-K (Aug 16, 2007)8-K (Aug 2, 2007)8-K (May 2, 2007)8-K (Apr 23, 2007)8-K (Feb 13, 2007)8-K (Feb 5, 2007)8-K (Jan 4, 2007)8-K (Nov 2, 2006)8-K (Aug 1, 2006)8-K (Jun 7, 2006)8-K (May 25, 2006)8-K (May 19, 2006)8-K (May 16, 2006)8-K (May 2, 2006)8-K (Apr 5, 2006)8-K (Feb 28, 2006)8-K (Jan 9, 2006)8-K (Jan 6, 2006)8-K (Nov 3, 2005)8-K (Oct 31, 2005)8-K (Sep 6, 2005)8-K (Sep 1, 2005)8-K (Aug 16, 2005)8-K (Jun 13, 2005)8-K (May 16, 2005)8-K (May 5, 2005)8-K (Apr 27, 2005)8-K (Apr 21, 2005)8-K (Apr 13, 2005)8-K (Mar 21, 2005)8-K (Feb 8, 2005)8-K (Feb 4, 2005)8-K (Feb 3, 2005)8-K (Jan 20, 2005)8-K (Jan 11, 2005)8-K (Jan 10, 2005)8-K (Dec 23, 2004)8-K (Dec 15, 2004)8-K (Dec 2, 2004)8-K (Dec 1, 2004)8-K (Nov 29, 2004)8-K (Nov 15, 2004)8-K (Nov 5, 2004)8-K (Nov 4, 2004)8-K (Oct 29, 2004)8-K (Oct 22, 2004)8-K (Sep 29, 2004)8-K (Sep 22, 2004)8-K (Sep 16, 2004)8-K (Aug 17, 2004)8-K (Aug 13, 2004)8-K (Aug 3, 2004)8-K (Jun 8, 2004)8-K (May 21, 2004)8-K (May 5, 2004)8-K (Apr 26, 2004)8-K (Mar 18, 2004)8-K (Feb 4, 2004)8-K (Jan 21, 2004)8-K (Jan 8, 2004)8-K (Nov 12, 2003)8-K (Nov 6, 2003)8-K (Oct 22, 2003)8-K (Aug 13, 2003)8-K (Jul 24, 2003)8-K (Jun 17, 2003)8-K (Jun 5, 2003)8-K (May 13, 2003)8-K (Mar 24, 2003)8-K (Feb 21, 2003)8-K (Feb 18, 2003)8-K (Feb 7, 2003)8-K (Feb 4, 2003)8-K (Jan 6, 2003)8-K (Dec 10, 2002)8-K (Dec 9, 2002)8-K (Nov 22, 2002)8-K (Nov 7, 2002)8-K (Oct 2, 2002)8-K (Aug 29, 2002)8-K (Aug 14, 2002)8-K (Jul 1, 2002)8-K (Jun 12, 2002)8-K (May 22, 2002)8-K (May 9, 2002)8-K (Apr 11, 2002)8-K (Mar 19, 2002)8-K (Mar 7, 2002)8-K (Feb 26, 2002)8-K (Jan 16, 2002)8-K (Jan 8, 2002)8-K (Nov 27, 2001)8-K (Nov 8, 2001)8-K (Oct 5, 2001)8-K (Aug 21, 2001)8-K (Aug 13, 2001)8-K (Aug 9, 2001)8-K (Jul 27, 2001)8-K (Jul 17, 2001)8-K (Jun 21, 2001)8-K (Jun 14, 2001)8-K (Jun 13, 2001)8-K (May 24, 2001)8-K (May 23, 2001)8-K (May 9, 2001)8-K (May 7, 2001)8-K (Mar 30, 2001)8-K (Mar 26, 2001)8-K (Feb 22, 2001)8-K (Feb 16, 2001)8-K (Feb 6, 2001)8-K (Jan 22, 2001)8-K (Dec 21, 2000)8-K (Dec 19, 2000)8-K (Nov 8, 2000)8-K (Nov 7, 2000)8-K (Nov 6, 2000)8-K (Nov 2, 2000)8-K (Sep 18, 2000)8-K (Aug 17, 2000)8-K (Jun 7, 2000)8-K (May 12, 2000)8-K (Apr 19, 2000)8-K (Mar 24, 2000)8-K (Mar 21, 2000)8-K (Mar 20, 2000)8-K (Feb 23, 2000)8-K (Feb 22, 2000)8-K (Jan 11, 2000)8-K (Jul 14, 1999)8-K (Apr 6, 1999)8-K (Jan 15, 1999)8-K (Dec 7, 1998)8-K (Nov 4, 1998)8-K (Jul 17, 1998)8-K (Jun 30, 1998)8-K (Mar 10, 1997)8-K (Feb 28, 1997)8-K (Jan 27, 1997)8-K (Jan 16, 1997)8-K (Dec 20, 1996)8-K (Nov 4, 1996)8-K (Jul 22, 1996)8-K (Jun 25, 1996)8-K (May 29, 1996)8-K (Apr 30, 1996)8-K (Apr 24, 1996)8-K (Mar 22, 1996)8-K (Feb 8, 1996)8-K (Oct 27, 1995)8-K (Jul 20, 1995)

Other

Enzon Pharmaceuticals 8-K 2009

Documents found in this filing:

c56699_8k.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

February 19, 2009

ENZON PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

Delaware	0-12957	22-2372868
(State or other jurisdiction of incorporation)	(Commission File No.)	(IRS Identification No.)


685 Route 202/206, Bridgewater, New Jersey		08807
(Address of principal executive offices)		(Zip Code)


Registrant’s telephone number, including area code		(908) 541-8600

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)

o	Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition.

On February 19, 2009, Enzon Pharmaceuticals, Inc. issued a press release reporting certain financial and other information for the quarter and fiscal year ended December 31, 2008. A copy of the press release is attached as Exhibit 99.1 to this Current Report and is incorporated by reference into this Item 2.02.

The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liability of that Section, nor shall such information be deemed to be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as otherwise stated in that filing.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.	Description

99.1	Press Release of Enzon Pharmaceuticals, Inc. dated February 19, 2009

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: February 19, 2009

	By:	/s/ Craig A. Tooman
		Craig A. Tooman Executive Vice President, Finance and Chief Financial Officer

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

Enzon Pharmaceuticals (ENZN)

Annual Reports

Quarterly Reports

8-K

Other

Documents found in this filing: